NAV Price | $11.82 |
NAV Daily Change ($) | $0.26 |
NAV Daily Change (%) | 2.25% |
NAV YTD Return | 9.14% |
The Morningstar Analyst Rating™ is based on the covering Morningstar Analyst's conviction in the fund's ability to outperform its peer group and/or relevant benchmark on a risk-adjusted basis over the long term. Harbor offers several funds with Gold, Silver, or Bronze ratings. |
Inception Date | 11/1/2000 |
Net Expense Ratio | 0.87% |
Gross Expense Ratio | 0.87% |
Total Net Assets (million) as of 1/31/2023 | $649.939 |
Ticker | HASGX |
Fund Number | 2010 |
Share Class | Institutional |
Ascendis Pharma A/S Sponsored ADR [ASND] | 3.2% |
Alkermes Plc [ALKS] | 3.0% |
Innoviva Inc. [INVA] | 2.9% |
Churchill Downs Incorporated [CHDN] | 2.7% |
Shift4 Payments Inc. Class A [FOUR] | 2.7% |
Spirit Realty Capital Inc. [SRC] | 2.5% |
Smartsheet Inc. Class A [SMAR] | 2.5% |
Encore Wire Corporation [WIRE] | 2.5% |
Option Care Health Inc [OPCH] | 2.5% |
Saia Inc. [SAIA] | 2.4% |
% of Total Holdings: | 26.9% |
The Morningstar Analyst Rating™ is based on the covering Morningstar Analyst's conviction in the fund's ability to outperform its peer group and/or relevant benchmark on a risk-adjusted basis over the long term. Harbor offers several funds with Gold, Silver, or Bronze ratings. |
“So much money today is managed by machines and people with an incredibly short term focus, making it an ideal time to be a long term fundamental investor.”
Will Muggia. President
CEO and CIO, Westfield Capital Management Company, L.P.
12/16/2022
12/19/2022
12/19/2022
0.00000
--
0.52004
--
0.00000
0.52004
0.52004
0.00000
10.68
12/17/2021
12/20/2021
12/20/2021
0.00000
--
4.21827
1.07866
0.00000
3.13961
4.21827
0.00000
14.34
12/16/2020
12/17/2020
12/17/2020
0.00000
0.00000
1.29572
0.47151
0.00000
0.82421
1.29572
0.00000
17.95
12/13/2019
12/16/2019
12/16/2019
0.00000
0.00000
0.47959
0.00000
0.00000
0.47959
0.47959
0.00000
13.68
12/14/2018
12/17/2018
12/17/2018
0.00000
0.00000
2.76487
0.40776
0.00000
2.35711
2.76487
0.00000
10.25
12/15/2017
12/18/2017
12/18/2017
0.00000
0.00000
1.45598
0.21806
0.00000
1.23792
1.45598
0.00000
14.33
12/16/2016
12/19/2016
12/19/2016
0.00000
0.00000
0.06026
0.00000
0.00000
0.06026
0.06026
0.00000
12.91
12/16/2015
12/17/2015
12/17/2015
0.00000
0.00000
1.58234
0.04157
0.00000
1.54077
1.58234
0.00000
12.00
12/17/2014
12/18/2014
12/18/2014
0.00000
0.00000
2.31921
0.46805
0.00000
1.85116
2.31921
0.00000
13.66
12/16/2013
12/17/2013
12/17/2013
0.00000
0.00000
2.12549
0.41041
0.00000
1.71508
2.12549
0.00000
14.25
12/14/2012
12/17/2012
12/17/2012
0.00000
0.03605
0.55958
0.00000
0.00000
0.55958
0.59563
0.00000
11.67
12/15/2011
12/16/2011
12/16/2011
0.00000
0.00000
0.98108
0.00000
0.00000
0.98108
0.98108
0.00000
10.63
12/16/2010
12/17/2010
12/17/2010
0.00000
0.00000
0.42401
0.00000
0.00000
0.42401
0.42401
0.00000
12.68
12/17/2009
12/18/2009
12/18/2009
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
9.79
12/18/2008
12/19/2008
12/19/2008
0.00000
0.00000
0.23760
0.00000
0.00000
0.23760
0.23760
0.00000
7.02
12/18/2007
12/19/2007
12/19/2007
0.00000
0.00000
1.93115
0.00000
0.00000
1.93115
1.93115
0.00000
12.28
12/18/2006
12/19/2006
12/19/2006
0.00000
0.00000
1.22060
0.00000
0.00000
1.22060
1.22060
0.00000
12.76
12/19/2005
12/20/2005
12/20/2005
0.00000
0.00000
1.05345
0.00000
0.00000
1.05345
1.05345
0.00000
12.52
12/29/2004
12/30/2004
12/30/2004
0.00000
0.00000
0.81883
0.00000
0.00000
0.81883
0.81883
0.00000
12.93
12/29/2003
12/30/2003
12/30/2003
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
12.46
12/27/2002
12/30/2002
12/30/2002
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
8.53
12/26/2001
12/27/2001
12/28/2001
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
0.00000
10.74
Ascendis Pharma A/S Sponsored ADR [ASND]
Denmark
233
122.13
28,409
3.2
Alkermes Plc [ALKS]
United States
1,043
26.13
27,263
3.0
Innoviva Inc. [INVA]
United States
1,987
13.25
26,322
2.9
Churchill Downs Incorporated [CHDN]
United States
116
211.43
24,623
2.7
Shift4 Payments Inc. Class A [FOUR]
United States
437
55.93
24,420
2.7
Spirit Realty Capital Inc. [SRC]
United States
570
39.93
22,755
2.5
Smartsheet Inc. Class A [SMAR]
United States
577
39.36
22,696
2.5
Encore Wire Corporation [WIRE]
United States
163
137.56
22,472
2.5
Option Care Health Inc [OPCH]
United States
740
30.09
22,266
2.5
Saia Inc. [SAIA]
United States
104
209.68
21,704
2.4
Inspire Medical Systems Inc. [INSP]
United States
85
251.88
21,521
2.4
ITT Inc. [ITT]
United States
251
81.10
20,330
2.3
National Vision Holdings Inc. [EYE]
United States
481
38.76
18,645
2.1
Lincoln Electric Holdings Inc. [LECO]
United States
127
144.49
18,382
2.0
Flywire Corp. [FLYW]
United States
745
24.47
18,236
2.0
WillScot Mobile Mini Holdings Corp. Class A [WSC]
United States
400
45.17
18,090
2.0
Hexcel Corporation [HXL]
United States
303
58.85
17,854
2.0
Wingstop Inc. [WING]
United States
129
137.62
17,819
2.0
American Assets Trust Inc. [AAT]
United States
647
26.50
17,136
1.9
Bio-Rad Laboratories Inc. Class A [BIO]
United States
40
420.49
16,778
1.9
Atkore Inc [ATKR]
United States
146
113.42
16,564
1.8
PDC Energy Inc. [PDCE]
United States
261
63.48
16,582
1.8
Northern Oil and Gas Inc. [NOG]
United States
518
30.82
15,962
1.8
Advanced Drainage Systems Inc. [WMS]
United States
193
81.97
15,858
1.8
First Interstate BancSystem Inc. Class A [FIBK]
United States
409
38.65
15,799
1.8
Samsara Inc. Class A [IOT]
United States
1,215
12.43
15,102
1.7
Endeavor Group Holdings Inc. Class A [EDR]
United States
659
22.54
14,864
1.7
Amedisys Inc. [AMED]
United States
172
83.54
14,338
1.6
Lantheus Holdings Inc [LNTH]
United States
274
50.96
13,964
1.6
NexTier Oilfield Solutions Inc. [NEX]
United States
1,505
9.24
13,905
1.6
Dynatrace Inc. [DT]
United States
357
38.30
13,666
1.5
Azenta Inc. [AZTA]
United States
233
58.22
13,586
1.5
Axalta Coating Systems Ltd. [AXTA]
United States
531
25.47
13,517
1.5
Primerica Inc. [PRI]
United States
92
141.82
13,025
1.5
BRP Inc. [DOOO]
Canada
169
76.35
12,932
1.4
Sensata Technologies Holding PLC [ST]
United States
318
40.38
12,828
1.4
Haemonetics Corporation [HAE]
United States
163
78.65
12,818
1.4
WNS (Holdings) Limited Sponsored ADR [WNS]
India
159
79.99
12,705
1.4
Rocket Pharmaceuticals Inc. [RCKT]
United States
612
19.57
11,979
1.3
F5 Inc. [FFIV]
United States
79
143.51
11,343
1.3
BRP Group Inc. Class A [BRP]
United States
440
25.14
11,071
1.2
StepStone Group Inc. Class A [STEP]
United States
404
25.18
10,179
1.1
Tenable Holdings Inc. [TENB]
United States
254
38.15
9,707
1.1
Kinsale Capital Group Inc. [KNSL]
United States
37
261.52
9,646
1.1
SiTime Corporation [SITM]
United States
93
101.62
9,486
1.1
UMH Properties Inc. [UMH]
United States
589
16.10
9,478
1.1
Synaptics Incorporated [SYNA]
United States
96
95.16
9,097
1.0
Avient Corporation [AVNT]
United States
262
33.76
8,844
1.0
Casella Waste Systems Inc. Class A [CWST]
United States
111
79.31
8,836
1.0
Apellis Pharmaceuticals Inc. [APLS]
United States
146
51.71
7,552
0.8
Planet Fitness Inc. Class A [PLNT]
United States
91
78.80
7,157
0.8
Karuna Therapeutics Inc. [KRTX]
United States
36
196.50
7,100
0.8
AAON Inc. [AAON]
United States
90
75.32
6,804
0.8
Palomar Holdings Inc. [PLMR]
United States
150
45.16
6,788
0.8
Prometheus Biosciences Inc [RXDX]
United States
59
110.00
6,458
0.7
Coupa Software Inc. [COUP]
United States
76
79.17
6,019
0.7
Arcutis Biotherapeutics Inc [ARQT]
United States
345
14.80
5,103
0.6
WEX Inc. [WEX]
United States
29
163.65
4,681
0.5
Ranpak Holdings Corp Class A [PACK]
United States
592
5.77
3,416
0.4
Fate Therapeutics Inc. [FATE]
United States
312
10.09
3,148
0.4
Total
--
--
--
859,627
95.9
Cash and Other Assets Less Liabilities
--
--
--
--
4.1
Total Net Assets
--
--
--
--
100%
Health Care
26.5
23.1
Industrials
20.0
17.9
Information Technology
17.5
19.7
Consumer Discretionary
9.0
10.8
Financials
7.4
5.7
Real Estate
5.5
2.2
Energy
5.2
7.4
Materials
2.9
4.5
Communication Services
1.7
2.3
Consumer Staples
0.0
4.5
Utilities
0.0
1.7
Materials
18.9
7.9
Energy
15.2
16.9
Consumer Discretionary
13.5
5.1
Communication Services
11.1
-0.8
Information Technology
8.4
4.9
Real Estate
7.4
8.7
Industrials
4.9
7.4
Health Care
0.4
-3.2
Utilities
0.0
0.9
Consumer Staples
0.0
11.2
Financials
-13.3
0.8
Westfield Capital Management Company, L.P. is dedicated to providing superior and consistent investment performance based on a disciplined, team-based approach, with exceptional client service. Westfield believes their greatest strength comes from the collective wisdom of a fully engaged and inspired team working together with clear objectives. Additionally, Westfield embraces their partnership structure, which aligns the advancement of the organization with their clients, and serves to attract and retain exceptional talent.
From time to time, certain fees and/or expenses have been voluntarily or contractually waived or reimbursed, which has resulted in higher returns. Without these waivers or reimbursements, the returns would have been lower. Voluntary waivers or reimbursements may be applied or discontinued at any time without notice. Only the Board of Trustees may modify or terminate contractual fee waivers or expense reimbursements.
There is no guarantee that the investment objective of the Fund will be achieved. Stock markets are volatile and equity values can decline significantly in response to adverse issuer, political, regulatory, market and economic conditions. Stocks of small cap companies pose special risks, including possible illiquidity and greater price volatility than stocks of larger, more established companies.
The Morningstar Analyst Rating™ is not a credit or risk rating. It is a subjective evaluation performed by Morningstar’s manager research group, which consists of various Morningstar, Inc. subsidiaries (“Manager Research Group”). In the United States, that subsidiary is Morningstar Research Services LLC, which is registered with and governed by the U.S. Securities and Exchange Commission. The Manager Research Group evaluates funds based on five key pillars, which are process, performance, people, parent, and price. The Manager Research Group uses this five-pillar evaluation to determine how they believe funds are likely to perform relative to a benchmark over the long term on a risk adjusted basis. They consider quantitative and qualitative factors in their research. For actively managed strategies, people and process each receive a 45% weighting in their analysis, while parent receives a 10% weighting. For passive strategies, process receives an 80% weighting, while people and parent each receive a 10% weighting. For both active and passive strategies, performance has no explicit weight as it is incorporated into the analysis of people and process; price at the share-class level (where applicable) is directly subtracted from an expected gross alpha estimate derived from the analysis of the other pillars. The impact of the weighted pillar scores for people, process and parent on the final Analyst Rating is further modified by a measure of the dispersion of historical alphas among relevant peers. For certain peer groups where standard benchmarking is not applicable, primarily peer groups of funds using alternative investment strategies, the modification by alpha dispersion is not used.
The Analyst Rating scale is Gold, Silver, Bronze, Neutral, and Negative. For active funds, a Morningstar Analyst Rating of Gold, Silver, or Bronze reflects the Manager Research Group’s expectation that an active fund will be able to deliver positive alpha net of fees relative to the standard benchmark index assigned to the Morningstar category. The level of the rating relates to the level of expected positive net alpha relative to Morningstar category peers for active funds. For passive funds, a Morningstar Analyst Rating of Gold, Silver, or Bronze reflects the Manager Research Group’s expectation that a fund will be able to deliver a higher alpha net of fees than the lesser of the relevant Morningstar category median or 0. The level of the rating relates to the level of expected net alpha relative to Morningstar category peers for passive funds. For certain peer groups where standard benchmarking is not applicable, primarily peer groups of funds using alternative investment strategies, a Morningstar Analyst Rating of Gold, Silver, or Bronze reflects the Manager Research Group’s expectation that a fund will deliver a weighted pillar score above a predetermined threshold within its peer group. Analyst Ratings ultimately reflect the Manager Research Group’s overall assessment, are overseen by an Analyst Rating Committee, and are continuously monitored and reevaluated at least every 14 months.
For more detailed information about Morningstar’s Analyst Rating, including its methodology, please go to https://shareholders.morningstar.com/investor-relations/governance/Compliance--Disclosure/default.aspx.
The Morningstar Analyst Rating (i) should not be used as the sole basis in evaluating a fund, (ii) involves unknown risks and uncertainties which may cause the Manager Research Group’s expectations not to occur or to differ significantly from what they expected, and (iii) should not be considered an offer or solicitation to buy or sell the fund.